NextFin news, On Thursday, October 2, 2025, surgeons at Molinette Hospital in Turin performed a groundbreaking nerve graft surgery that restored natural erections in patients who had undergone prostate removal due to cancer. This pioneering procedure addresses a common complication of prostatectomy—erectile dysfunction—by reconstructing the nerves responsible for erectile function.
The surgical team, led by Dr. Giovanni Bianchi, utilized nerve grafts to reconnect the cavernous nerves damaged or removed during prostate cancer surgery. These nerves are critical for natural erectile function, and their injury often results in impotence. The innovative technique involves harvesting nerves from other parts of the patient’s body and grafting them to the affected area to restore nerve signaling.
The procedure was conducted at Molinette Hospital, a leading medical center in Turin, Italy, known for its advanced urological treatments. The surgery took place as part of a clinical trial aimed at improving quality of life for prostate cancer survivors, who frequently face sexual dysfunction after treatment.
According to Dr. Bianchi, the nerve graft surgery represents a major step forward in urological oncology and reconstructive surgery. "This technique allows us to offer patients a chance to regain natural erectile function, which was previously considered very difficult or impossible after prostate removal," he stated.
The need for this advancement arises from the high incidence of erectile dysfunction following radical prostatectomy, a standard treatment for prostate cancer. Damage to the neurovascular bundles during surgery often leads to permanent sexual impairment, significantly affecting patients’ psychological and emotional well-being.
The nerve graft procedure works by bridging the gap created when nerves are removed or damaged during prostatectomy. Surgeons carefully identify and connect donor nerves to the penile nerves, facilitating the regeneration of nerve fibers and restoration of erectile function over time.
Early results from the clinical trial at Molinette Hospital are promising, with several patients reporting the return of spontaneous erections within months after surgery. The team plans to continue monitoring outcomes to validate the long-term effectiveness and safety of the technique.
This breakthrough has attracted attention from the international medical community, as it offers hope for millions of men worldwide who suffer from erectile dysfunction after prostate cancer treatment. The Turin team’s work may set a new standard for post-prostatectomy care and rehabilitation.
The surgery was performed following rigorous ethical approval and patient consent, ensuring adherence to medical standards and patient safety. The hospital emphasized that while the procedure is innovative, it requires specialized surgical expertise and is currently available only in select centers.
In summary, the nerve graft surgery developed and implemented by Turin surgeons at Molinette Hospital on October 2, 2025, marks a historic advancement in restoring natural erectile function after prostate removal. This technique offers renewed hope for prostate cancer survivors seeking to regain sexual health and improve their quality of life.
Explore more exclusive insights at nextfin.ai.
